Who makes Epiduo® Gel left face?

Epiduo® Gel left face is developed by GWT-TUD GmbH.

What development phase is Epiduo® Gel left face in?

Epiduo® Gel left face is FDA-approved (marketed).

Last reviewed 2026-05-14 · How we verify

Epiduo® Gel left face

GWT-TUD GmbH · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	Epiduo® Gel left face
Also known as	Adapalen 0,1% and Benzoylperoxid 2,5%
Sponsor	GWT-TUD GmbH
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Pilot Study of Tolerability and Effectivity of Two Combination Topical Acne Products (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Epiduo® Gel left face CI brief — competitive landscape report
Epiduo® Gel left face updates RSS · CI watch RSS
GWT-TUD GmbH portfolio CI